S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial. (October 2021)

• Record Type: Journal Article
• Authors: Khanna, Sahil; Kelly, Colleen R.; Louie, Thomas; Fisher, Monika; Hota, Susy; Misra, Bharat; Van Hise, Nicholas W.; Yen, Eugene F.; Bullock, Jeff S.; Pullman, John; Nathan, Richard; Silverman, Michael; Davis, Ian; McGill, Sarah; Gerardin, Ylaine; Silva, Josh; Pardi, Darrell; Orenstein, Robert; Grinspan, Ari; El-Nachef, Najwa; Kraft, Colleen S.; Budree, Shrish; Borody, Thomas J.; Kassam, Zain; Allegretti, Jessica R.
• Is Part Of: American journal of gastroenterology. Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
• Page Start: S57
• Page End: S57
• Publication Date: 2021-10
• Subjects: Stomach -- Diseases -- Periodicals; Intestines -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Gastrointestinal Diseases -- Periodicals; Electronic journals; Periodicals; 616.33
• DOI: 10.14309/01.ajg.0000772996.83378.7c
• Languages: English
• ISSNs: 0002-9270